FDA seeks input on draft guidance involving device, drug trials

12/12/2012 | Clinica (subscription required)

The FDA has issued draft guidance intended to help institutional review boards, clinical trial sponsors and researchers assess investigator qualifications, decide whether research sites are adequate and determine whether an investigational device exemption or investigational new drug application is necessary to protect human subjects. The guidance is up for comment through Jan. 22.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY